Near Infrared Imaging

Near Infrared Imaging (NII) is on the cusp of causing a paradigm shift in medical imaging. NII’s patented technologies are revolutionary, life-saving, safe, non radiation, non-contact, non-invasive and affordable to the worldwide population. Near Infrared Imaging (NII) incorporated in 2009 as an LLC, merged into a Delaware INC, is a “Corporation In Good Standing” with the Commonwealth of Massachusetts and has filed and paid all of its Federal and State taxes every year. Near Infrared Imaging is owned in part by: - The Regents of the University of California (UCLA) - The City University of New York (CUNY) - Lawrence Livermore National Laboratory (LLNL) Their #1 competitor spent $23M to get to this same point that they are now. They accomplished this with $800,000. There are no VC or Angel investors. All of their investors are Mom and Pop investors who believe in the technology and the NII team. They only have 3M shares Authorized and 2M shares Outstanding. They will limit dilution and plan on an early exit strategy. Near Infrared Imaging’s first product is the Vein-Eye™, a vein illumination camera that is priced significantly less than the leading selling devices. The Vein-Eye is already selling in more than 35 countries and generating profits and cash flow. They have over 45 distributors and are adding a distributor a week. This is all done with virtually no marketing, advertising, and a very limited sales force. Investment funds will go directly to increasing sales and releasing new products already in development.